Expand LENZ Menu
LENZ MENU

LENZ Latest Press Releases

-- August 11, 2026 --

LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- August 4, 2026 --

LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 Globe Newswire 4:05 PM

-- July 6, 2026 --

LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ for the Treatment of Presbyopia Globe Newswire 8:15 AM

-- June 24, 2026 --

LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ in Australia and New Zealand Globe Newswire 8:30 AM

-- June 7, 2026 --

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ (LNZ100) in Greater China Globe Newswire 7:30 PM

-- May 26, 2026 --

LENZ Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- May 11, 2026 --

LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- May 4, 2026 --

LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference Globe Newswire 8:00 AM

-- April 23, 2026 --

LENZ Therapeutics, Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- April 20, 2026 --

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ for the Treatment of Presbyopia in the United Kingdom Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes